All ETFs

Watch Compare

CNCR

ETF

CNCR · UNKNOWN · 75 holdings

Quick Summary

Price History

Concentration Risk

26,85% Moderate spread

Low risk High risk

The top 10 holdings only account for 26,85%. No single stock can meaningfully hurt this fund — you'd need a broad market selloff to see real damage.

Top Holdings Today

Weighted by position size

RXRX

▲ 5,93%

PGEN

▼ -1,52%

CMPX

▲ 7,54%

GNLX

▲ 7,58%

EXEL

▼ -3,45%

DNA

▲ 0,91%

REPL

▲ 16,92%

BMY

▼ -0,33%

SDGR

▲ 4,11%

Weighted avg. of top holdings ▲ 4,21%

Sector Allocation

Healthcare

61,77%

Manufacturing

27,06%

Top 10 Holdings

26,85% of fund

RXRX Recursion Pharmaceuticals Inc

4,01%

PGEN Precigen Inc

3,05%

CMPX Compass Therapeutics Inc

2,99%

GNLX Genelux Corp

2,90%

SWTX SpringWorks Therapeutics Inc

2,86%

EXEL Exelixis Inc

2,48%

DNA Ginkgo Bioworks Holdings Inc

2,33%

REPL Replimune Group Inc

2,14%

BMY Bristol-Myers Squibb Co

2,10%

SDGR Schrodinger Inc/United States

1,98%

Other positions

0,65%

All Holdings (75)

Top 10: 26,85% of fund

#	Ticker	Name	Weight	Shares	Market Value
1	RXRX	Recursion Pharmaceuticals Inc	4,01%	47 707	358 279,57
2	PGEN	Precigen Inc	3,05%	157 416	272 329,68
3	CMPX	Compass Therapeutics Inc	2,99%	92 038	266 910,2
4	GNLX	Genelux Corp	2,90%	61 963	259 005,34
5	SWTX	SpringWorks Therapeutics Inc	2,86%	4 426	255 645,76
6	EXEL	Exelixis Inc	2,48%	5 730	221 693,7
7	DNA	Ginkgo Bioworks Holdings Inc	2,33%	25 263	208 167,12
8	REPL	Replimune Group Inc	2,14%	15 047	190 795,96
9	BMY	Bristol-Myers Squibb Co	2,10%	3 149	187 743,38
10	SDGR	Schrodinger Inc/United States	1,98%	7 925	176 806,75
11	BPMC	Blueprint Medicines Corp	1,97%	1 824	176 143,68
12	ZYME	Zymeworks Inc	1,89%	12 581	168 585,4
13	VOR	Vor BioPharma Inc	1,88%	155 827	168 293,16
14	HCM	HUTCHMED China Ltd	1,76%	9 522	156 732,12
15	IPHA	Innate Pharma SA	1,73%	72 695	154 113,4
16	GLUE	Monte Rosa Therapeutics Inc	1,73%	28 005	154 027,5
17	IBRX	ImmunityBio Inc	1,66%	45 097	148 369,13
18	MRUS	Merus NV	1,65%	3 136	147 674,24
19	ELVN	Enliven Therapeutics Inc	1,64%	7 033	146 497,39
20	RVMD	Revolution Medicines Inc	1,61%	3 534	143 975,16
21	BNTX	BioNTech SE	1,61%	1 275	143 973,0
22	IMCR	Immunocore Holdings PLC	1,57%	4 770	140 094,9
23	SNDX	Syndax Pharmaceuticals Inc	1,51%	8 648	135 254,72
24	GMAB	Genmab A/S	1,50%	5 921	134 288,28
25	ACLX	Arcellx Inc	1,48%	2 045	132 556,9
26	MRK	Merck & Co Inc	1,38%	1 335	123 153,75
27	INBX	Inhibrx Biosciences Inc	1,34%	9 030	119 647,5
28	AURA	Aura Biosciences Inc	1,32%	15 787	118 244,63
29	XNCR	Xencor Inc	1,28%	7 442	114 309,12
30	MGNX	MacroGenics Inc	1,26%	45 885	112 877,1
31	ALLO	Allogene Therapeutics Inc	1,25%	57 024	111 196,8
32	ARVN	Arvinas Inc	1,24%	6 259	110 784,3
33	SMMT	Summit Therapeutics Inc	1,24%	5 340	110 484,6
34	KPTI	Karyopharm Therapeutics Inc	1,22%	13 708	108 980,72
35	LEGN	Legend Biotech Corp	1,20%	3 069	107 445,69
36	NUVL	Nuvalent Inc	1,18%	1 404	105 271,92
37	DAWN	Day One Biopharmaceuticals Inc	1,17%	11 547	104 615,82
38	JANX	Janux Therapeutics Inc	1,16%	3 155	103 767,95
39	KYMR	Kymera Therapeutics Inc	1,14%	3 247	101 793,45
40	ACRV	Acrivon Therapeutics Inc	1,14%	19 124	101 548,44
41	RCUS	Arcus Biosciences Inc	1,14%	9 313	101 418,57
42	NUVB	Nuvation Bio Inc	1,13%	51 266	100 994,02
43	REGN	Regeneron Pharmaceuticals Inc	1,07%	137	95 727,38
44	NRIX	Nurix Therapeutics Inc	1,07%	6 187	95 589,15
45	RAPT	RAPT Therapeutics Inc	1,07%	83 716	95 436,24
46	ITOS	iTeos Therapeutics Inc	1,06%	13 008	94 438,08
47	ACET	Adicet Bio Inc	1,06%	104 924	94 305,69
48	TYRA	Tyra Biosciences Inc	1,02%	7 811	91 466,81
49	CRBU	Caribou Biosciences Inc	1,02%	77 530	90 710,1
50	IMRX	Immuneering Corp	1,01%	54 838	90 482,7
51	LYEL	Lyell Immunopharma Inc	1,01%	126 923	90 216,87
52	ZNTL	Zentalis Pharmaceuticals Inc	0,99%	42 768	88 529,76
53	IDYA	Ideaya Biosciences Inc	0,98%	4 274	87 916,18
54	TSVT	2seventy bio Inc	0,97%	32 721	86 383,44
55	FHTX	Foghorn Therapeutics Inc	0,92%	16 997	82 435,45
56	CGEM	Cullinan Therapeutics Inc	0,88%	9 296	78 923,04
57	APLM	Apollomics Inc	0,87%	11 835	78 111,0
58	ERAS	Erasca Inc	0,86%	55 811	76 461,07
59	AGEN	Agenus Inc	0,83%	25 886	73 775,1
60	BCYC	Bicycle Therapeutics PLC	0,77%	6 304	69 154,88
61	AUTL	Autolus Therapeutics PLC	0,76%	39 347	68 070,31
62	IOVA	Iovance Biotherapeutics Inc	0,76%	16 044	67 946,34
63	STRO	Sutro Biopharma Inc	0,76%	42 537	67 633,83
64	YMAB	Y-mAbs Therapeutics Inc	0,75%	12 098	67 264,88
65	RLAY	Relay Therapeutics Inc	0,74%	19 407	66 177,87
66	GERN	Geron Corp	0,71%	36 015	63 386,4
67	KURA	Kura Oncology Inc	0,65%	7 542	58 148,82
68	BMEA	Biomea Fusion Inc	0,64%	19 723	56 999,47
69	RPTX	Repare Therapeutics Inc	0,63%	47 406	55 939,08
70	IMTX	Immatics NV	0,61%	12 364	54 154,32
71	PRLD	Prelude Therapeutics Inc	0,51%	60 533	45 944,55
72	FATE	Fate Therapeutics Inc	0,50%	39 744	44 513,28
73	MRSN	Mersana Therapeutics Inc	0,47%	79 891	41 814,95
74	TNGX	Tango Therapeutics Inc	0,38%	16 378	33 902,46
75	IGMS	IGM Biosciences Inc	0,15%	9 936	13 512,96

Showing top 10 of 75 holdings · Listed: 99,35% · 0,65% in other positions

Related ETFs

IWV

iShares Russell 3000 ETF

▲ 0,75%

VTHR

Vanguard Russell 3000 ETF

▲ 0,77%

ITOT

iShares Core S&P Total U.S. Stock Market ETF

▲ 0,74%

IWM

iShares Russell 2000 ETF

▲ 0,25%

SCHA

Schwab U.S. Small-Cap ETF

▼ -0,03%

Objectif de Cours des Analystes

Aucune couverture d'analyste disponible

Growth

Rev 5Y: N/A · Earnings 1Y: N/A

Revenue Growth (1Y)	N/A	Revenue Growth (3Y)	N/A
Earnings Growth (1Y)	N/A	Earnings Growth (3Y)	N/A
Revenue Growth (5Y)	N/A	Earnings Growth (5Y)	N/A

Profitability

ROE: N/A · Net Margin: N/A

Revenue (TTM)	N/A	Net Income (TTM)	N/A
ROE	N/A	ROA	N/A
Gross Margin	N/A	Operating Margin	N/A
Net Margin	N/A	Free Cash Flow (TTM)	N/A
ROIC	N/A	FCF Growth (3Y)	N/A

Safety

D/E: N/A · Current: N/A

Debt / Equity	N/A	Current Ratio	N/A
Interest Coverage	N/A	Asset Turnover	N/A
Working Capital	N/A	Tangible Book Value	N/A

Dividends

Yield: N/A · Payout: N/A

Dividend Yield	N/A	Payout Ratio	N/A
Dividend Growth (3Y)	N/A	Dividend Growth (5Y)	N/A
Consecutive Div Years	N/A

Valuation

P/E: N/A · EV/EBITDA: N/A

P/E Ratio	N/A	Forward P/E	N/A
P/B Ratio	N/A	P/S Ratio	N/A
PEG Ratio	N/A	Forward PEG	N/A
EV/EBITDA	N/A	Fwd EV/EBITDA	N/A
Forward P/S	N/A	Fwd Earnings Yield	N/A
FCF Yield	N/A
Market Cap	N/A	Enterprise Value	N/A